We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIZ icon
551
Assurant
AIZ
$13.8B
$1.36M 0.02%
12,643
-88,402
-87% -$9.36M
SRNE
552
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.36M 0.02%
310,000
– –
LNG icon
553
Cheniere Energy
LNG
$54.5B
$1.35M 0.02%
19,429
– –
EFX icon
554
Equifax
EFX
$21B
$1.35M 0.02%
10,320
– –
TWTR
555
DELISTED
Twitter, Inc.
TWTR
$1.34M 0.02%
47,101
+1,690
+4% +$59.8K
M icon
556
Macy's
M
$6.54B
$1.34M 0.02%
38,461
+4,758
+14% +$177K
MLAB icon
557
Mesa Laboratories
MLAB
$536M
$1.34M 0.02%
7,200
– –
ESPR
558
DELISTED
Esperion Therapeutics
ESPR
$1.33M 0.02%
30,000
– –
BLFS icon
559
BioLife Solutions
BLFS
$1.46B
$1.33M 0.02%
+76,000
New +$1.5M
WBD icon
560
Warner Bros
WBD
$63.6B
$1.33M 0.02%
41,565
– –
ARDX icon
561
Ardelyx
ARDX
$1.27B
$1.3M 0.02%
300,000
– –
TRGP icon
562
Targa Resources
TRGP
$58.2B
$1.29M 0.02%
22,990
-516
-2% -$27.5K
WDAY icon
563
Workday
WDAY
$36.9B
$1.28M 0.02%
8,782
+368
+4% +$51.1K
ABMD
564
DELISTED
Abiomed Inc
ABMD
$1.28M 0.02%
2,840
+147
+5% +$57.9K
SJM icon
565
J.M. Smucker
SJM
$13B
$1.27M 0.02%
12,378
+2,910
+31% +$318K
CSGP icon
566
CoStar Group
CSGP
$12.1B
$1.26M 0.02%
+29,870
New +$1.28M
VMC icon
567
Vulcan Materials
VMC
$36.8B
$1.24M 0.02%
11,182
+930
+9% +$108K
RHI icon
568
Robert Half
RHI
$4.02B
$1.23M 0.02%
17,473
+3,154
+22% +$231K
SRRA
569
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.22M 0.02%
18,000
– –
ANGO icon
570
AngioDynamics
ANGO
$570M
$1.22M 0.02%
56,000
– –
DISCK
571
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.21M 0.02%
41,006
-556
-1% -$14.5K
DOC icon
572
Healthpeak Properties
DOC
$15.4B
$1.21M 0.02%
45,900
+1,770
+4% +$46.5K
REG icon
573
Regency Centers
REG
$15.1B
$1.2M 0.02%
18,583
+1,903
+11% +$121K
GHDX
574
DELISTED
Genomic Health, Inc.
GHDX
$1.19M 0.02%
17,000
-23,000
-58% -$1.35M
MSCI icon
575
MSCI
MSCI
$41.4B
$1.19M 0.02%
+6,716
New +$1.17M
21 22
23
24 25

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.